Black Friday saleUp to 70% OFF
000

AHN-GOOK PHARMACEUTICAL CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

001540 chart


Full chart

Key stats


Market capitalization
‪79.41 B‬ KRW
Dividend yield (indicated)
3.18%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
1,260 KRW
Net income (FY)
‪1.29 B‬ KRW
Revenue (FY)
‪233.68 B‬ KRW
Shares float
‪4.40 M‬
Beta (1Y)
0.32

Employees


Employees (FY)
389
Change (1Y)
+64 +19.69%
Revenue / Employee (1Y)
‪461.34 K‬ KRW
Net income / Employee (1Y)
‪2.55 K‬ KRW

About AHN-GOOK PHARMACEUTICAL CO., LTD.


Sector
Health Technology
Headquarters
Seoul
Founded
1955
Website
ahn-gook.com
ISIN
KR7001540004
FIGI
BBG000BXPLH2
AHN-GOOK PHARMACEUTICAL Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include health function food, medical equipment, quasi-drugs, over-the-counter drugs, ethical drugs and recommended products such as Binosto effervescent tablet, Tobicom-S soft capsule, Levotension tablet and TobicomKid Q-10 chewable tablets. The company was founded by Noh Jong-Hyeong on September 16, 1955 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 001540 is 6,930 KRW — it has increased by 0.14% in the past 24 hours. Watch AHN-GOOK PHARMACEUTICAL CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange AHN-GOOK PHARMACEUTICAL CO., LTD. stocks are traded under the ticker 001540.
001540 stock has risen by 0.87% compared to the previous week, the month change is a −2.67% fall, over the last year AHN-GOOK PHARMACEUTICAL CO., LTD. has showed a −16.30% decrease.
001540 reached its all-time high on Jul 6, 2015 with the price of 34,250 KRW, and its all-time low was 1,550 KRW and was reached on Jun 4, 2004. View more price dynamics on 001540 chart.
See other stocks reaching their highest and lowest prices.
001540 stock is 1.30% volatile and has beta coefficient of 0.32. Track AHN-GOOK PHARMACEUTICAL CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is AHN-GOOK PHARMACEUTICAL CO., LTD. there?
Today AHN-GOOK PHARMACEUTICAL CO., LTD. has the market capitalization of ‪78.65 B‬, it has increased by 3.61% over the last week.
Yes, you can track AHN-GOOK PHARMACEUTICAL CO., LTD. financials in yearly and quarterly reports right on TradingView.
001540 net income for the last quarter is ‪−410.15 M‬ KRW, while the quarter before that showed ‪9.64 B‬ KRW of net income which accounts for −104.26% change. Track more AHN-GOOK PHARMACEUTICAL CO., LTD. financial stats to get the full picture.
Yes, 001540 dividends are paid annually. The last dividend per share was 220.00 KRW. As of today, Dividend Yield (TTM)% is 3.18%. Tracking AHN-GOOK PHARMACEUTICAL CO., LTD. dividends might help you take more informed decisions.
AHN-GOOK PHARMACEUTICAL CO., LTD. dividend yield was 2.34% in 2023, and payout ratio reached 193.81%. The year before the numbers were 2.39% and 36.41% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 28, 2024, the company has 389.00 employees. See our rating of the largest employees — is AHN-GOOK PHARMACEUTICAL CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AHN-GOOK PHARMACEUTICAL CO., LTD. EBITDA is ‪12.81 B‬ KRW, and current EBITDA margin is 4.09%. See more stats in AHN-GOOK PHARMACEUTICAL CO., LTD. financial statements.
Like other stocks, 001540 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AHN-GOOK PHARMACEUTICAL CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AHN-GOOK PHARMACEUTICAL CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AHN-GOOK PHARMACEUTICAL CO., LTD. stock shows the sell signal. See more of AHN-GOOK PHARMACEUTICAL CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.